Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine Booster Doses in Kidney Transplant Recipients: Results of a 12-mo Follow-up From a Prospective Observational Study.

Total SARS-CoV-2 IgG antibody levels first increased after vaccination with the third dose ( P < 0.001; paired Wilcoxon test; Figure 2 A) and then were stable with a slightly increasing trend during the 12-mo follow-up ( P < 0.001; Figure 2 A).

also in 192 other papers